Poseida Therapeutics, Inc. Total Assets
Poseida Therapeutics, Inc. had Total Assets of $293.58 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2024-11-07
- 2024-09-30: Assets $293.58M.
- 2024-06-30: Assets $298.69M.
- 2024-03-31: Assets $262.58M.
- 2023-12-31: Assets $273.88M.
| Period end | Assets |
|---|---|
| 2024-09-30 | $293.58M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $298.69M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $262.58M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $273.88M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $302.25M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $281.21M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $313.62M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $351.84M 10-K · filed 2024-03-07 |
| 2022-09-30 | $380.48M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $205.46M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $248.15M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $269.31M 10-K · filed 2023-03-09 |
| 2021-09-30 | $261.94M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $299.11M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $333.34M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $371.48M 10-K · filed 2022-03-10 |
| 2020-09-30 | $405.17M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $226.35M 10-Q · filed 2020-08-20 |
| 2019-12-31 | $147.00M 10-K · filed 2021-03-11 |